EU Says Ranbaxy India Site Safe, Despite FDA Warnings

European regulators on Thursday said a key Ranbaxy Laboratories Inc. site in India doesn't pose a risk to public health, just months after the U.S. Food and Drug Administration banned imports...

Already a subscriber? Click here to view full article